Recall archive / FDA device enforcement
BD PYXIS MEDBANK MINI CR-2HH-1FH-P, REF: 169-114 containing software version 3.9.1.9 — FDA record Z-2485-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jun 24, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- BD PYXIS MEDBANK MINI CR-2HH-1FH-P, REF: 169-114 containing software version 3.9.1.9
- Reason
- Due to software issue, there is a potential when a restock label is printed for a medication stored in automated dispensing cabinets, that the incorrect bin for the medication is printed on the label.
- Classification
- Class II
- Recalling firm
- CareFusion 303, Inc.
- Quantity
- 84 units
- Agency-reported status
- Ongoing
- Source record identifier
- Z-2485-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | UDI: 10885403512544/ Serial Number: 16132658 16168374 16097985 16191227 16221557 16203700 16198296 16034793 16207656 16221556 16225067 16138830 16039764 15950395 16042993 15967360 15378118 16155519 16090203 16216083 16112389 16035948 16256357 15940923 15940150 15961968 15950397 15950399 16055233 15442769 16243553 15832653 16085678 16044038 16044042 16044015 16044016 16044019 16044022 16044021 16044034 16044026 16044032 16044027 16044029 16044031 16044046 15499064 15948854 15490767 15631138 15378120 15378121 15409640 15910842 15353919 15547821 15049511 15618006 15371604 15872431 15657867 15364475 15506571 15326870 15906089 15906091 15906093 15328486 15442778 15506570 16061648 16061659 16061660 16034792 15353916 16161290 16271157 16271158 16271159 16042049 16042051 16042052 16042053 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
US Nationwide distribution including in the states of AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Aug 14, 2024
- Recall initiation date
- Jun 24, 2024
- Center classification date
- Aug 2, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.